Newsweek: How to Stop Crypto, A Deadly Disease So Neglected It’s Missed on the ‘Neglected’ List
“…[U.S.-based] Immuno Mycologics, aka Immy, started out in the late ’70s with a modest goal: make simpler tools to diagnose fungal infections. It’s now one of the fastest-growing private companies in the nation, built entirely on unique diagnostics. One of its most important developments in recent years is a rapid test, the Cryptococcal Antigen Lateral Flow Assay, or CrAg LFA, which global health experts believe could be key to stopping one of the planet’s biggest killers: cryptococcal meningitis…” (Adams, 1/4).